Daily SPAC Update – November 18, 2024

by | Nov 18, 2024

GBBK Extends and Gets New Sponsor. GLobal Star (GLST) Extension Vote Set. FTII, IPXX Extension Votes.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

ABOUT THE SPAC DAILY
Get the latest insights into the SPAC market with an in-depth look at recent vote outcomes, redemptions, deal announcements, and liquidations. Discover which SPACs gained and lost the most yesterday, IPO performance stats, upcoming extension votes, and notable trust value changes. Stay informed on the latest SPAC trends and opportunities.

SPAC DEAL & EXTENSION VOTES SET
GLST – Global Star Acquisition Inc * EXTENSION VOTE SET: Nov 27, 2024 * trust $11.43

SPAC VOTE RESULTS
GBBK – GLOBAL BLOCKCHAIN ACQUISITION CORP * Extend to Aug 12, 2025 * 61,086 redeemed

EXTENSION VOTES
FTII – FUTURETECH II ACQUISITION CORP * Extend to August 18, 2025
IPXX – INFLECTION POINT ACQUISITION CORP II * extend from November 30, 2024 to August 21, 2025

OTHER SPAC NEWS
PLMJ – PLUM ACQUISITION CORP III * Investor Deck
THCP – THUNDER BRIDGE CAPITAL PARTNERS IV INC * Investor Deck

NEW SPAC IPOs
Nov 15: HSPT – Horizon Space Acquisition Ii Corp. $60M IPO

YESTERDAY’S TOP SPAC GAINERS
12.36% ~ $ 13.09 | CCTS – Cactus Acquisition Corp. 1 Ltd (Announced)
8.79% ~ $ 12.25 | ALCY – Alchemy Investments Acquisition Corp 1 (Pre-Deal)
2.77% ~ $ 11.33 | WAVS – Western Acquisition Ventures Corp. (Announced)
2.30% ~ $ 11.99 | ATEK – Athena Technology Acquisition Corp. II (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-5.10% ~ $ 6.70 | TMTC – TMT Acquisition Corp. (Announced)
-2.94% ~ $ 11.89 | BLAC – Bellevue Life Sciences Acquisition Corp. (Announced)
-2.69% ~ $ 12.67 | DPCS – DP Cap Acquisition Corp I (Pre-Deal)
-1.45% ~ $ 10.90 | FTII – Future Tech II Acquisition Corp. (Announced)
-1.05% ~ $ 11.39 | MCAA – Mountain Co. I Acquisition Corp. (Announced)

LATEST SPAC IPO PERFORMANCE
Nov 08 | $ 9.99 | ASPC – SPAC III Acquisition Corp.
Nov 08 | $ 9.96 | WLAC – Willow Lane Acquisition Corp.
Nov 07 | $ 10.00 | GSRT – GSR III Acquisition Corp.
Nov 04 | $ 10.00 | BACQ – Bleichroeder Acquisition Corp. I
Nov 01 | $ 9.96 | NTWO – Newbury Street II Acquisition Corp
Oct 24 | $ 10.05 | OACC – Oaktree Acquisition Corp. III
Oct 24 | $ 10.00 | CHAR – Charlton Aria Acquisition Corp
Oct 22 | $ 10.00 | ALDF – Aldel Financial II Inc.

Recent Analysis

Daily SPAC Update – December 2, 2024

BACQ, RDAC, CCIR Start Separate Trading. BREZ, JWSM, MNTN Shareholders Approve Extensions. ROCL Deal Approved. AITR + American Metals Deal Terminated.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.